San Francisco, CA, United States of America

Casper deClerq


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 664(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cardiac Treatment by Casper deClerq

Introduction

Casper deClerq is an innovative inventor based in San Francisco, CA. He has made significant contributions to the field of cardiac treatment, particularly in the area of atrial fibrillation. His work focuses on developing advanced methods and apparatus for improving patient outcomes.

Latest Patents

Casper deClerq holds a patent for "Methods of epicardial ablation." This invention provides apparatus and methods for mapping conduction pathways and creating transmural lesions in the heart wall for the treatment of atrial fibrillation. The apparatus includes at least one epicardial ablation probe with a plurality of electrodes designed to create a transmural lesion. This technology facilitates the formation of a transmural lesion that electrically isolates the pulmonary veins from the surrounding myocardium without cutting or penetrating the pericardial reflections.

Career Highlights

Casper deClerq is currently employed at Epicor, Inc., where he continues to work on innovative solutions in the medical field. His expertise in cardiac technologies has positioned him as a valuable asset to the company and the industry.

Collaborations

Throughout his career, Casper has collaborated with notable professionals, including Matthias Vaska and Daniel D Merrick. These collaborations have further enhanced his work and contributed to advancements in cardiac treatment technologies.

Conclusion

Casper deClerq's contributions to the field of cardiac treatment through his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to pave the way for advancements in the treatment of atrial fibrillation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…